Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
Aventis is in the early stages of a plan to consolidate marketing-communications duties for its worldwide brands, the company confirmed last week. The estimated $300 million global advertiser begins the process with oncology drugs Taxotere and Genasense. Companies affected are within Havas, IPG, WPP and Omnicom. Havas’ Euro RSCG has Lantus; IPG’s McCann-Erickson handles Allegra. Neither is immediately affected.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in